Morgan & Morgan Announces Investigation of Auspex Pharmaceuticals, Inc. - ASPX

NEW YORK, April 1, 2015 /PRNewswire/ -- Morgan & Morgan, P.C. announces that it is investigating potential claims against the board of directors of Auspex Pharmaceuticals, Inc. ("Auspex" or the "Company") (NasdaqGS: ASPX) concerning possible breaches of fiduciary duty and other violations of state law related to the sale of the Company to Teva Pharmaceuticals Industries Ltd.  The transaction is valued at approximately $3.5 billion.

If you own shares of Auspex and would like to learn more about the Auspex investigation, you may contact Morgan & Morgan at 1(800) 732-5200 or email [email protected].

Our investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Auspex for not acting in the Company's shareholders' best interests in connection with the sale.

About Morgan & Morgan

Morgan & Morgan is one of the nation's largest 200 law firms. In addition to shareholder rights, the firm also practices in the areas of antitrust, personal injury, consumer protection, overtime, and product liability. All of the Firm's legal endeavors are rooted in its core mission: provide investor and consumer protection and always fight "for the people."

Attorney advertising.  Prior results do not guarantee a similar outcome.

Contact:
Morgan & Morgan
Peter Safirstein, Esq.
28 West 44^th Street
Suite 2001
New York, NY  10036
1-800-732-5200
[email protected]

SOURCE Morgan & Morgan

Related Links

http://www.securitieslawfirm.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED